Assessment of the risk of developing cefepime-induced abnormal liver enzyme levels using the albumin–bilirubin score and fibrosis-4 index: a single-centre retrospective case–control study
The progression of liver fibrosis before cefepime administration, as assessed using the FIB-4 index, could be more useful than the ALBI score in predicting the risk of developing abnormal liver enzyme levels.
Authors
- Takuya Iwamoto (ORCID: https://orcid.org/0000-0002-6445-4410)
- H Katsu
- Ryuji HIRANO
- Yuki Asai (ORCID: https://orcid.org/0000-0002-1933-8592)
Institutions
- Mie University Hospital (JP)
- Nagoya Medical Center (JP)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1093/jac/dkaf291
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00